SCHEMBL22349482

SCHEMBL22349482

C#Cc1ccc(Nc2ncnc3c2ncn3[C@H]2C[C@H](O)[C@@H](CO)O2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.56
▸ SLC29A1 Q99808 2/20 0.56
▸ ADK P55263 1/20 0.54
▸ LMNA P02545 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ GLA P06280 1/20 0.53
▸ PMP22 Q01453 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ NPY1R P25929 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ NPY2R P49146 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ THPO P40225 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18862688 1.00 HIF1A (0.56) HIF1ASLC29A1ADKLMNAALDH1A1
SCHEMBL7990561 0.88 LMNA (0.68) HIF1ASLC29A1ADKLMNAALDH1A1
SCHEMBL20925387 0.83 ADORA1 (0.56) HIF1ASLC29A1ADKLMNAALDH1A1
SCHEMBL22349483 0.82 HIF1A (0.64) HIF1ASLC29A1
SCHEMBL2284604 0.81 HIF1A (0.67) HIF1ASLC29A1
SCHEMBL2284612 0.81 HIF1A (0.67) HIF1ASLC29A1
SCHEMBL18486201 0.81 SLC29A1 (0.57) HIF1ASLC29A1ADKLMNAALDH1A1
SCHEMBL23982373 0.80 HIF1A (0.71) HIF1ASLC29A1
SCHEMBL6267085 0.80 HIF1A (0.71) HIF1ASLC29A1
SCHEMBL548569 0.80 HIF1A (0.71) HIF1ASLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10744209-B2 Biodegradable polymeric nanoparticle conjugates and use thereof NEW YORK UNIVERSITY (US) 2020-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10744209-B2 Biodegradable polymeric nanoparticle conjugates and use thereof CD47, SLC46A1, ABCB1 HIF1A 238/4885SLC29A1 388/4885ADK 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback